Jeroen Rouwkema is currently an Associate Professor in the Department of Biomechanical Engineering at the University of Twente. Jeroen received his doctoral degree from the University of Twente under the supervision of prof. Clemens van Blitterswijk. Prior to this, he worked 6 months in the lab of prof. Robert (Bob) Langer at MIT, USA. Between 2014 and 2015 he was also appointed as a Visiting Researcher at Harvard Medical School, USA, in the group of Prof. Ali Khademhosseini.
His expertise and interests are tissue engineering, vascularization, and the role that biomechanical signals play in these processes. He has published in multiple high-impact journals, including Nature Biotechnology (IF 41.5), Advanced Materials (IF19.0), TRENDS in Biotechnology (4x, IF 12.0), and PNAS (2x, IF 9.7). He has directed approximately € 3 million in research funding.
Jeroen has received a VENI fellowship from NWO, as well as an International Outgoing Fellowship, which is part of the Marie Skłodowska-Curie actions of the European Commission. In 2017 he received a European Research Council (ERC) Consolidator grant and in 2019 and in 2021 an ERC Proof of Concept grant. In 2017 he also received the TERMIS EU Robert Brown Early Career Principal Investigator Award.
For more info about Jeroen Rouwkema on the 'Featured Scientists' page, click below:
Dr. Rouwkema focuses on tuning the local mechanical and chemical micro-environment in order to control development and organization of vascularized engineered tissues. Adding a vascular network to an engineered tissue is a promising method to enhance tissue integration and survival after implantation. The engineered vascular network can connect to the vasculature of the patient, resulting in a faster perfusion with blood and therefore a better supply of nutrients and oxygen.
For more information see the following website: http://www.vascularizationlab.com/
- Lorenzo Moroni, MERLN Institute for Technology-Inspired Regenerative Medicine, Maastricht University
- Albert van den Berg, the BIOS Lab-on-a-Chip group, University of Twente
- Ying Yang, Keele University, Stoke-on-Trent, UK
- Ali Khademhosseini, Harvard – MIT Health Science and Technology, Cambridge, USA